International Medical Devices Share Discussion Threads

[soldi] 29/8/2007 12:18

jotoha1 - could you please explain the background to your post.

[jotoha1] 29/8/2007 10:42

Hope you guys realise but some very hurt investors are looking to instruct a class action against Thomas and co, for his actions with FAR...INTERESTING DEVELOPMENT TO SAY THE LEAST!

[martincoops] 26/7/2007 08:56

Good luck James lets hope we see that 7p soon, only another 1p before I am in profit at long last :)

[james t kirk] 26/7/2007 08:46

I've just bought back in with 25k, will update header later..

[martincoops] 26/7/2007 08:34

HERE WE GO THEN

RNS Number:9007A
International Medical Devices PLC
26 July 2007


International Medical Devices Plc
("IMD" or "the Company")


NHS works with IMD to fast-track safety needles into the NHS catalogue


IMD is delighted to announce the launch of two manually retractable hypodermic
safety needles.


Having been originally developed under the project name 'ClipOn', IMD is to
launch the first products in its SuretyTM range of safety devices under the
brand names SuretyTM Needle and SuretyTM Needle+. The products are to be
launched via IMD's 100% owned subsidiary, Response Medical.


During the course of the last 12 months in England and Wales 147 million
hypodermic needles were purchased via the NHS Supply Chain catalogue and the
number of safety devices in use has now grown to 14 million per year.


The Company has had a number of successful product evaluations and continues to
work closely with the NHS with a view to inclusion of its safety needles in the
NHS Supply Chain catalogue. The decision by NHS officials to fast-track IMD's
safety devices into the catalogue ahead of the official needles contract renewal
date of summer 2008 is largely due to the innovative and unique design of the
needles.


Group Commercial Director, Matthew Root commented;


"Following a number of recent meetings with senior representatives of the NHS,
we now expect inclusion of the safety needles as Blue Diamond products in the
NHS Supply Chain catalogue within the next two months. We are also planning to
launch a range of complementary safety IV injection and phlebotomy devices under
the SuretyTM brand over the next 18 months."

[kappa3] 23/7/2007 11:54

forecast for 2008 is 112% growth on 2007 ---clearly not a well known or popular share which is a shame as prospects look good but share price doesn't yet know which way is up!!!

[ljsquash] 11/7/2007 12:45

Wait and see yet again I agree!

[martincoops] 11/7/2007 12:43

And as per normal the price goes down, might top up but getting abit fed up now with this one... Still going to hold long term though

[ljsquash] 03/7/2007 07:52

Impressive!

[martincoops] 03/7/2007 07:12

Well that sounds like a very positive update.

[ged5] 26/6/2007 09:39

That's true. They were going to have the trial production by the end of June. Well there's still 3 more trading days left.

I just hope that the safety needle isn't going to be our nemesis.

[ljsquash] 26/6/2007 09:32

Looks good but still no news on the Clipon?

[ged5] 26/6/2007 09:24

More good news out this morning but as yet no comment. Perhaps everyone is taking you seriously mryesyes :)

[mryesyes] 24/6/2007 23:20

ALERT ALERT, the guy in charge was also in charge of farsight plc, they changed advisor just before they disappeared without trace you have been warned

[ged5] 22/6/2007 12:00

Silent_Angel,

When I first came across INT I wasn't sure if they were going to become a medical equipment developer or a medical equipment distributor.

After reading the broker note, there now seems to be a focus on distribution. They already have a number of products they are distributing but it also says that any acquisitions will be selected to add to the supply of new medical products.

The company's new structure is now clearly defined on page 2 of the Finn broker note.

I only use the word 'seem' because I took the word of the company at face value when they first stated the supply of Clipon to the NHS. I am now sceptical until I see tangible evidence.

That said the future doesn't look too bleak being in a market which is steadily growing at 8-10% per year. There seems plenty to suggest that the 7p target for 2007 can be reached.

[silent_angel] 22/6/2007 09:30

Thanks for your informative post Ged5,
When you say their 'seems to be a stratagy',
What do you think that stratagy 'seems' to be?

[singsing] 21/6/2007 10:11

Accumulation in progress, hence the hush hush. Once they have loaded up you won't beable to get rid of them.

[ged5] 20/6/2007 15:05

Thanks Chaweewan!

Just thinking out loud really. Was hoping to get get some comments back. Seems to be in coma this share.

[chaweewan] 18/6/2007 10:12

Ged5
Thank you for your reasoned info. - such a relief from the rubbish on other BBs

[james t kirk] 18/6/2007 07:10

Sssshhhhhhhhhhh...

[ljsquash] 16/6/2007 14:28

I noticed that to! lol.

[sir josephs mate] 15/6/2007 21:14

very quiet here!!

[ged5] 20/5/2007 12:06

Just trawling through some of my mistakes which have now become long term investments.

Although still very risky when looking at the cash/debt of INT I still think it's possible for substantial gains over the next two years.

I note on the website the JM Finn brokers note dated the 1st May gives a target price of 7p for this year. Reading through their estimates for sales and profits this is likely to increase in 2008 with the possibility of a dividend(some turnaround if that happens!!).

Key issues seem to be the the launch of Clipon in the NHS. You're right martin in that we should have some news in June/July. Trials are now scheduled for June with an expected launch in Autumn. The excuse for the delays seems rather lame to me and I think that it is this delay which is holding back the share price

The other issue which could have a big effect on the share price is the FDA approval which should happen later this year.

Cashflow seems as though its likely to improve.
The business nows seems to be clearly defined.
There seems to be a strategy.
Sales look as though they are going to improve.
It looks like INT will make a maiden profit.

All in all it seems like a good hold with the possibility of adding later in the year. IMO

Don't forget to sell soon EJ we wouldn't want you holding once it starts to rise. Wouldn't be good for your image!! lol